This is the text extract for January Tender notification, browse documents here.
29 January 2010
TENDER RESULTS
The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 23 December 2008. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th February 2010. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing (where applicable) for tender winning brand at the tender subsidy will occur on 1 March 2010, reference pricing of non-tender winning brand will occur on 1 May 2010 and Sole Subsidised Supply commences on 1 August 2010.
The decisions were as follows:
Chemical Name
Presentation; Pack size and type Handrub 1% with ethanol 70%; 500 ml, bottle Crm 10%; 20 g OP, tube Tab 160 mg; 30 tablets, bottle
Current Subsidy (Current Price) $5.40 $4.26 ($4.45) $74.25 $19.00 (25 tests)
New tender subsidy $4.60 $3.79 $57.92
Sole supply brand (Supplier) healthE (Jaychem) Itch-Soothe (AFT) Apo-Megestrol (Apotex) Innovacon hCG One Step Pregnancy Test Device (Inverness Medical)
Brands affected by reference pricing and delisting Orion (Orion) Eurax (Novartis Consumer) Megace (BMS) MDS Quick Card (MDS Diagnostics)
Chlorehexidine gluconate Crotamiton* Megestrol acetate Pregnancy tests hCG urine
Cassette, 40 tests OP, box
$22.80
*This will become fully funded. Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – listing (where applicable) for hospital tender winning brands of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 March 2010; DV Limits and DV pharmaceuticals will apply from 1 May 2010; de-listing of other brands in Section H will occur on 1 May 2010.
The decisions were as follows:
Chemical Name
Presentation; Pack size and type Tab 160 mg; 30 tablets, bottle
Hospital Supply Brand (Supplier) Apo-Megestrol (Apotex)
Pack Price $57.92
DV Limit 1%
DV Pharmaceuticals Brand Name (Supplier) Megace (BMS)
Megestrol acetate
A333139 - qA12214
3. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 March 2010 and DV Limits and DV Pharmaceuticals will apply from 1 May 2010.
The decisions were as follows:
Chemical Name
Presentation; Pack size and type Crm 10%; 20 g, tube
Hospital Supply Brand (Supplier) Itch-Soothe (AFT)
Pack Price $3.79
DV Limit 1%
DV Pharmaceuticals Brand Name (Supplier) Eurax (Novartis Consumer) Cards hCG Urine (NZ Diagnostics Ltd) Cyrstal Clear (Douglas) Clearview Easy hCG (NZ Diagnostics Ltd) Clear Blue (Johnson & Johnson) Discover (Wilson Consumer) Discovery Pregnancy Planning Kit (Wilson Consumer) First Response (Wilson Consumer) Imagine (Point of Care) Femfresh (Wilson Consumer) Instant Pregnancy Tests (NZ Diagnostics) MDS Quick Card (MDS Diagnostics) MDS Quick Stick (MDS Diagnostics) Unimark (Biotech Atlantic)
Crotamiton
Pregnancy tests - hCG urine
Cassette, 40 tests, box
Innovacon hCG One Step Pregnancy $22.80 Test Device (Inverness Medical)
1%
Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 23 December 2008.
The decisions were as follows:
Chemical Name Dantrolene Sodium Dantrolene Sodium
Line Item Cap 25 mg Cap 50 mg
For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 23 December 2008 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.
A333139 - qA12214
Page 2 of 2
Metadata
Title
Abstract
29 January 2010 TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept tenders for Sole Subsidised Supply and Hospital Supply Status for some of the products listed in the Invitation to Tender dated 23…
Page 1
Note
This text has been extracted from the source PDF document.
Also available as plain text.
Please contact webmaster to discuss alternative format options.